Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

The Many Faces of Female Pattern Hair Loss: Its Presentation, Progression, and Treatment Through the Ages

Description

The session focuses on understanding female pattern hair loss (FPHL), examining its causes, stages (early and late), and available treatments. FPHL typically presents with decreased hair density and finer hair. While early stages may be reversible, later stages can lead to follicular loss, making treatment outcomes less favorable. Recognizing the various clinical patterns is essential for accurate diagnosis and consideration of coexisting conditions like frontal fibrosing alopecia. Early-onset FPHL in young women is often associated with high androgen levels and requires thorough hormonal assessment to guide treatment, often involving anti-androgens and 5-alpha reductase inhibitors. In later stages, particularly during menopause, androgens are lower, requiring different treatment strategies, such as minoxidil and non-hormonal therapies, to minimize health risks associated with imbalanced hormone levels. The session emphasizes the importance of established medical therapies like minoxidil and spironolactone, while also discussing newer alternatives including bicalutamide and nutraceuticals. Various adjunct therapies, including laser treatments and microneedling, may enhance hair growth when combined with traditional treatments. Overall, a multifaceted approach tailored to the individual’s hormonal profile and timing of hair loss onset is crucial for effective management of FPHL.

View more

Conclusions

  • Female Pattern Hair Loss (FPHL) is a phenotype of hair loss that can have multiple contributing factors.
  • Investigating the differences between early and late onset FPHL is necessary for effective treatment.
  • Medical therapy is essential in treating FPHL, especially those targeting androgens in early cases to halt progression.
  • Minoxidil serves as a vital monotherapy and is also effective in combination therapies for FPHL.
  • Postmenopausal women require special considerations regarding hormonally related treatments and their possible effects on estrogen levels.
  • Olsen 2005
  • Olsen et al JAAD 2006;55:1014-1023
  • Avram M, (2024), Abstracts. Lasers Surg Med, 56: S148-S149